ArticleMethods in molecular biology (Clifton, N.J.)2025
Quantitative Staging of Mid-blastula Zebrafish Embryos by Nuclei Counting.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise developmental staging of embryos is critical for experimental methods that compare different groups of embryos in developmental biology. During development, gene and protein expression levels change dynamically as cells acquire sequentially more restricted cell fates, from pluri- or multipotent cells to germ layers and to differentiated cells. In particular, zebrafish embryos experience rapid transcriptional changes at the mid-blastula transition, when zygotic transcription is activated in specific domains along the dorsoventral and anteroposterior axes and maternal transcripts are degraded. During these rapid and widespread transcriptional changes, precise staging is needed to accurately compare one group of experimental embryos to another that differ in some experimental variable, such as mutant versus wild-type embryos, or embryos receiving two different experimental treatments. Precise staging ensures that an observed change in gene or protein expression between the experimental groups is due to the experimental variable and not to a difference in developmental stage caused by asynchrony in early development. However, zebrafish embryos exhibit rapid cell divisions and subtle morphological changes during the mid-blastula period, making it difficult to accurately stage embryos using morphology or timing alone. Here, we present a method to quantitatively stage zebrafish embryos based on cell count during the mid-blastula period. Our method can be applied to any zebrafish experiment performed during the mid-blastula period, by counting nuclei in sibling embryos of the experimental ones. After staining with a nuclear marker, nuclei are imaged with a confocal microscope and then quickly identified and counted with standard imaging software. Overall, this quantitative staging method can increase experimental rigor and decrease variability in experiments during the mid-blastula period.
Indexed as
Identifiers
40418454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.